Related Experiment Video
Updated: Dec 10, 2025

Murine Renal Transplantation Procedure
Published on: July 10, 2009
Hemopericardium in a Sirolimus-Treated Renal Transplant Patient
Kevin Groudan1, Khalid Sawalha2, Anusha G Bhat1
1Internal Medicine, Baystate Medical Center, Springfield, USA.
Abstract:
Sirolimus is an immunosuppressant frequently prescribed to prevent graft-vs-host disease in renal transplant patients. Pericardial effusion is recognized as a rare and potentially lethal side effect of this medication. Hemopericardium, specifically, is an even rarer complication that has yet to be reported in the literature. We report the first case of sirolimus-induced hemopericardium in a renal transplant patient.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Kidney Transplant I: Introduction
Hemodialysis II: Procedure and Complications

